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Abstract
Background: Clinical ethics support, in particular Moral Case Deliberation, aims to support health care providers
to manage ethically difficult situations. However, there is a lack of evaluation instruments regarding outcomes of
clinical ethics support in general and regarding Moral Case Deliberation (MCD) in particular. There also is a lack of
clarity and consensuses regarding which MCD outcomes are beneficial. In addition, MCD outcomes might be
context-sensitive. Against this background, there is a need for a standardised but flexible outcome evaluation
instrument. The aim of this study was to develop a multi-contextual evaluation instrument measuring health care
providers’ experiences and perceived importance of outcomes of Moral Case Deliberation.
Methods: A multi-item instrument for assessing outcomes of Moral Case Deliberation (MCD) was constructed
through an iterative process, founded on a literature review and modified through a multistep review by ethicists
and health care providers. The instrument measures perceived importance of outcomes before and after MCD, as
well as experienced outcomes during MCD and in daily work. A purposeful sample of 86 European participants
contributed to a Delphi panel and content validity testing. The Delphi panel (n = 13), consisting of ethicists and
ethics researchers, participated in three Delphi-rounds. Health care providers (n = 73) participated in the content
validity testing through ‘think-aloud’ interviews and a method using Content Validity Index.
Results: The development process resulted in the European Moral Case Deliberation Outcomes Instrument
(Euro-MCD), which consists of two sections, one to be completed before a participant’s first MCD and the other after
completing multiple MCDs. The instrument contains a few open-ended questions and 26 specific items with a
corresponding rating/response scale representing various MCD outcomes. The items were categorised into the
following six domains: Enhanced emotional support, Enhanced collaboration, Improved moral reflexivity, Improved
moral attitude, Improvement on organizational level and Concrete results.
Conclusions: A tentative instrument has been developed that seems to cover main outcomes of Moral Case
Deliberation. The next step will be to test the Euro-MCD in a field study.
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Background
Traditionally, clinical ethics support has been conducted
by Clinical Ethics Committees and/or Clinical Ethics Con-
sultation [1,2]. A more recent form of clinical ethics sup-
port is Moral Case Deliberation (MCD) [3,4]. MCD is a
facilitator-led collective moral inquiry by health care pro-
viders into a concrete moral question connected to a real
case in their practice [5,6]. Often, MCD implies using a
specific conversation method (such as the Dilemma
method or the Socratic Dialogue) [6-10]. For the develop-
ment of the instrument in this study, we use the term
MCD as an umbrella term in line with the definition above
excluding the specific conversation methods. Related terms
that might be used instead of MCD are: Ethics rounds
[9-13], Ethical case discussion [14,15] and Ethics reflection
groups [16,17]. The MCD facilitator does not function as
an ethics expert or consultant [5,6,10]. The expertise of the
MCD facilitator supports the joint reasoning process, fos-
tering a sincere, systematic and constructive dialogue and
keeping in focus the moral dimension of the case [6].
The main goal of MCD is to support health care pro-
viders to manage ethically difficult situations in everyday
clinical practice. Empirical investigations are needed to
evaluate in which sense this main goal is reached and to
understand what outcomes are produced by MCD. Previ-
ous literature reveals four gaps that hamper further empir-
ical evaluation.
First, there is a lack of MCD evaluation research in
general using validated instruments [2,18,19].
Second, existing quantitative MCD evaluation research
using predetermined evaluation criteria have failed to detect
any outcomes [11,20]. The only previous MCD question-
naire published is the Dutch ‘Maastricht Moral Deliberation
Evaluation Questionnaire’ [21]. However, this questionnaire
was study-specific for a process evaluation of an implemen-
tation of MCD in a specific healthcare setting.
Third, the few available qualitative MCD evaluation
studies have merely focused on the evaluation of the
MCD sessions and little on the perceived outcomes of
the MCD on everyday clinical work [7-10,21].
Fourth, there is a lack of clarity and consensus on which
outcomes ideally should be reached. This requires a more
thorough consideration [2,22]. A lack of consensus does
not have to be a problem in itself, since goals of MCD can
change in different contexts and over time. At the same
time, this complicates selecting outcomes for MCD and
developing an instrument. The contextual nature of MCD
sessions prevents simple standardisation [22,23]. There-
fore, there is a need to study how outcomes differ and in
which ways they are context sensitive (for example influ-
enced by workplace, group dynamic behaviour, facilitator,
patient cases and culture). This variety regarding out-
comes stresses the need for an instrument that takes into
account a broad range of different aspects. Results
from using such an instrument can further inform and
stimulate the discussion of beneficial outcomes of
MCD, and thereby stimulate the professional develop-
ment of MCD (even if a final consensus will not and
need not be reached).
In sum, there is both a lack and need for a standardised
outcome evaluation instrument for MCD that is developed
according to rigid methodological standards and at the
same time able to capture outcomes in different contexts.
The fact that there is no consensus on MCD outcomes
does not diminish the importance of developing a stan-
dardized instrument. Instead it makes it even more import-
ant to develop an instrument that allows for variety of
different MCD outcomes in different contexts. Information
on the outcomes of MCD informs about the quality of
MCD which, in the end, will be beneficial for the health
care providers. Thus, the aim of this study was to develop
a multi-contextual evaluation instrument measuring health
care providers’ experiences and perceived importance of
outcomes of Moral Case Deliberation.
Methods
A multi-item instrument was developed with the following
method of measurement: literature review, collection of
items, categorization, a Delphi approach [24] and content
validity testing [25-27]. The construct being measured was
attitudes and experiences regarding possible outcomes of
Moral Case Deliberation, measured through a reflective
model [28]. The development process was inductive and
did not emanate from predetermined aspects of the con-
struct. An advisory statement including no objection to
test the instrument was given by Swedish Regional Ethical
Review Board (dnr 2012/34).
Participants
Overall, 86 participants contributed to the development
process of the instrument (Tables 1 and 2). A purposeful
sampling strategy was used. First, a Delphi panel of 13 key
informants was selected consisting of clinical ethicists and/
or ethics researchers from six different countries. Members
of the European Clinical Ethics Network (ECEN) [29] were
approached, as well as other clinical ethicists, in order to
foster variation (Table 1).
Second, 73 participants were approached as represen-
tatives of the target population, including healthcare
professions collaborating in patient care as well as social
scientists, knowledgeable in MCD practice and the
everyday English clinical language. They were asked to
participate in the process of cognitive and content valid-
ity testing. Variation was sought for different profes-
sional backgrounds, medical field, countries and level of
experience with MCD (Table 2).
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Literature review
An explorative literature review search was conducted by
MS to identify possible outcomes of clinical ethics support
in general. The review functioned as an inspiration source
and was aimed at generating a list of items and identifying
outcome domains. A PUBMED search was performed
with the MESH term ‘Ethics Consultation’, published 2002
to 2012 and the words ‘Moral Case Deliberation’ or ‘Ethics
rounds’ in title or abstracts. Papers were included if they
concerned (1) empirical studies of evaluation of Clinical
Ethics Consultation, Clinical Ethics Committees or MCD,
and (2) conceptual papers about aims of supporting health
care providers concerning clinical ethical issues. Reasons
for including papers on Clinical Ethics Consultation and
Clinical Ethics Committees were that these outcome mea-
sures could also be relevant for MCD and also as a response
to reported critique by participants of MCDs being too
much reflexivity oriented instead of action oriented [10,21].
Articles were excluded if they concerned only ethics
consultation for individual physicians, patients and fam-
ilies, research design issues about clinical ethics support
and education. No quality assessment of the involved pa-
pers was performed since the aim was only to develop a
list of possible outcomes.
Categorization
MS and BM started the categorisation process with the
purpose to build a preliminary conceptual model with three
measurement levels: items, subdomains and domains. First,
MS and BM grouped the various items into domains, inde-
pendent from each other. This was a bottom up process
(rather than top down or theoretically driven). Next, simi-
larities and differences between the two categorizations
as a heuristic tool were used until agreement on the meas-
urement levels existed (see Table 3). Similar items were
merged or grouped together and then coded into higher
abstraction levels of subdomains and domains [30].
Delphi approach
A Delphi approach of three rounds of structured question-
naires to the expert panel was used in order to gain con-
sensus without dominance on the process from specific
experts [24]. The purpose was to further test the categor-
isation of the selected outcome items and the content val-
idity of the items. Consensus was primarily sought for
categorisation and relevance of items, but also for the
structure of the instrument.
Delphi round 1
The Delphi panel was asked to independently categorise
the various items into subdomains, and subdomains into
domains. The participants were also asked to assess the
relevance of all items collected from the literature review
(both the items included in the categorisation and the
items discarded by MS and BM) on a four-point scale;
irrelevant to high relevance. In the light of the result,
items, subdomains, and domains were merged, discarded
or reformulated by MS and BM.
Delphi round 2
The panel received information on the categorisations and
opinions of all members (anonymously) and a question-
naire on the appropriateness of the new version of the cat-
egorisation. A four point scale: not (1), somewhat (2),
quite (3) and very appropriate (4) was used. In addition
respondents were requested to make comments and
Table 1 Characteristics of the members of the Delphi expert panel
Delphi-members Country Profession Ethicist Ethics researcher Female/Male ECEN* member Participation Delphi round
1 2 3
1 France Philosopher x x M x x x x
2 France Lawyer x x M x x x x
3 Germany Physician x M x x x x
4 Netherlands Nurse x F x x x
5 Netherlands Chaplain x M x x
6 Netherlands Health Scientist x x F x
7 Norway Physician x x M x x
8 Sweden Philosopher x M x
9 Switzerland Nurse x F x x
10 Switzerland Nurse x F x x x
11 Switzerland Philosopher x x M x x
12 Switzerland Physician x x F x x x
13 Switzerland Physician x F x x
*European Clinical Ethics Network.
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suggestions of re-categorisation. On the basis of the Del-
phi categorization rounds, a draft instrument was con-
structed for content validity testing. Effort was put into
reducing ambiguity in item wording and formulating
items into everyday language [26].
Delphi round 3
The panel received nine closed questions regarding ad-
equacy and clarity of the instruction, the questions and
the grading of the draft instrument, with possibilities
for comments.
Content validity testing on target population
Cognitive understanding and relevance of the items
were tested on 73 persons from the target population
(see Table 2). The testing was conducted through seven
steps with different groups of participants at each step,
using ratings of content validity index (CVI) and audio
Table 2 Characteristics of respondents in the content validity testing
Characteristics
respondents
Step I CVI*
and individual
think-aloud
Step II
CVI and
focus group
Step III
CVI mailed
Step IV CVI
and individual
think-aloud
Step V
CVI and
focus groups
Step VI
CVI and
focus group
Step VII
CVI and
think-aloud
Sum
mean (range)
Participants 5 11 16 14 12 5 5 73
Female/male 4/1 8/3 11/5 10/4 9/3 3/2 5/0 50/18
Age (years) 53 48 - 54 45 53 45 49 (37–68)
Experience of MCD 3 0 0 0 12 0 0 15
Profession
Nurse 3 4 2 5 2 1 5 22
Head/administrator 1 2 3 3 5 2 16
Ethicists/facilitators 3 4 7 1 15
Physician 2 3 1 1 7
Physiotherapist 3 1 1 5
Chaplain 1 2 2 5
Nurses assistant 3 5 8
Social scientist 2 2 4
Social worker 1 1 2
Other 1 1
Specialty
Medicine 2 2 4 1 9
Surgery 1 2 4 7
Psychiatry 1 3 1 5
Neurology 1 2 3
Home nursing care 4 4 7 15
Paediatrics 2 1 3
Geriatrics/Pall med** 3 1 4
Habilitation 5 1 6
Ethics support service 2 5 1 8
Other 1 2 7 1 3 14
Country
Sweden 5 11 14 30
Netherlands 7 12 19
Great Britain*** 9 9
France 5 5
Norway 10 10
*CVI = Content Validity Index [31] **Palliative medicine ***Members of UK Clinical Ethics Network.
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recorded ‘think-aloud’ interviews. Revisions were made
between each step.
Content Validity Index testing
The inter-rater agreement of clarity of the items was mea-
sured by CVI using the four-point scale according to
Yaghmaie: Not clear (1), Item needs some revision (2),
Clear but needs minor revision (3) and Very clear (4). The
relevance was measured on a four-point scale from irrele-
vant to high relevance [31]. The rater also had the oppor-
tunity to add comments. The questions on simplicity and
ambiguity were discarded, after a ‘think-aloud’ pilot test
that showed that the respondents gave identical answers
on these two aspects, compared to the answers on clarity.
Both the appropriateness of categorisation and the CVI
was computed according to Polit et al. as universal agree-
ment (S-CVI). An item-CVI (I-CVI) lower than .78 for
was considered as a reason for revision [27].
‘Think-aloud’ interviews
The cognitive method ‘think-aloud’ [25,26] was used while
respondents simultaneously filled in the CVI- Through.
individual- and focus group interviews [30], the under-
standing was tested for consistence and in accordance
with the way the items were intended to be perceived
[25,26]. The interviewers read the items aloud and encour-
aged the informants to express their meaning with the
question: ‘Can you rephrase this item in your own words?’
Furthermore, the participants were encouraged to express
opinions on the relevance of the items.
Table 3 Categorization and item tracking matrix the process of categorisation and reduction of items
Stages Domains Subdomains Items at
each step n
Coding
agreement
Revision
of items n
A* B C
Collection of items 96 - - - -
MS and BM categorisation Reduced moral distress Emotional support 48 50% 24 36 20
Better ability to prioritise
Received support to
handle ethical problems
Enhanced ethical climate Organisation consistent
with ethical standards
Enhanced collaboration
Enhanced communication
Concrete resolution
in patient cases
Answers or consensus
reached in the patient cases
Concrete steps taken in
the patient cases
Improved process for decision
making in the patient cases
Enhanced moral competence Improved moral skills
Improved moral attitude
Improved ethics knowledge
Delphi round 1: Enhanced emotional support
(Subdomains discarded and
abstraction level for domains lowered)
33 25% 6 10 29
Improved cooperation & communication
Better coherence with
organizational policy
Clear results
Improved moral skills
Improved moral attitude
Delphi round 2 Enhanced emotional support
(Meaning of one domain was changed
and three domains were reformulated)
26 75% 4 6 18
Enhanced collaboration
Improvement on organizational level
Concrete results
Improved moral reflexivity
Improved moral attitude
*A =merged, B = discarded, C = reformulated.
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Results
The European Moral Case Deliberation Outcome Instru-
ment (Euro-MCD) was developed in accordance with
the following steps.
Literature review
The literature search yielded 1378 articles. After reviewing
titles according to the inclusion criteria, the number was re-
duced to 352 papers. After reading the abstract or, in case
of insufficient information, the full text, 87 papers which
fulfilled the relevant criteria were included for further ana-
lysis. The major content of these papers were conceptual
and empirical studies on Clinical Ethics Consultation and
15 addressed MCD (umbrella term). At the end of the de-
velopment process, the final items referred to 21 papers,
where nine addressed MCD (Table 4).
Collection of items
A total of 96 preliminary items were collected from the
contents of 53 of the 87 papers. In the first reduction
step, items were reduced by MS and BM to 48 (Table 3)
based on six criteria: similar items, not relevant enough
for MCD, too academic, too vague, too unspecific to be
categorised to only one domain, too abstract or difficult
to measure (Table 5).
First categorization
The resulting 48 items were sorted into 12 subdomains,
which were attributed into four overarching thematic do-
mains: ‘Enhanced ethical climate’, ‘Enhanced moral compe-
tence’, ‘Reduced moral distress’ and ‘Concrete resolution’.
For agreement, item reduction and domain revision see
the tracking matrix in Table 3.
Table 4 Final model of categorisation
Domains Items References
Enhanced emotional support* 1. Enhances possibility to share difficult emotions and thoughts with co-workers [5,8,10]
2. Strengthens my self-confidence when managing ethically difficult situations [10]
3. Enables me to better manage the stress caused by ethically difficult situations [6,8,23,32]
4. Increases awareness of my own emotions regarding ethically difficult situations [5,14]
5. I feel more secure to express doubts or uncertainty regarding ethically difficult situations [6,8,33,34]
Enhanced collaboration 6. Greater opportunity for everyone to have their say [8,10]
7. Better mutual understanding of each other’s reasoning and acting [8,10,21]
8. Enhances mutual respect amongst co-workers [2,14,21]
9. I and my co-workers manage disagreements more constructively [1,35]
10. More open communication among co-workers [2,8,10,21]
Improved moral reflexivity 11. Develops my skills to analyse ethically difficult situations [1,6,15,35,36]
12. Increases my awareness of the complexity of ethically difficult situations [9,21]
13. Develops my ability to identify the core ethical question in the difficult situations [10,15,21,34,37]
14. I see the ethically difficult situations from different perspectives [8-10,14,21,38]
15. Enhances my understanding of ethical theories (ethical principles, values and norms) [15,34]
Improved moral attitude 16. I become more aware of my preconceived notions [6,10,12]
17. I gain more clarity about my own responsibility in the ethically difficult situations [9,10,12]
18. I listen more seriously to others’ opinions [14,21]
19. Gives me more courage to express my ethical standpoint [21]
20. I understand better what it means to be a good professional [21]
Impact on organizational level 21. I and my co-workers become more aware of recurring ethically difficult situations [33,35]
22. Contributes to the development of practice/policies in the workplace [21]
23. I and my co-workers examine more critically the existing practice/policies
in the workplace/organization
(new)
Concrete results 24. Find more courses of actions in order to manage the ethically difficult situation [34,35,39,40]
25. Consensus is gained amongst co-workers in how to manage the ethically difficult situations [9,15,40]
26. Enables me and my co-workers to decide on concrete actions in order to manage
the ethically difficult situations
[2,15,36,37]
*References [11-13].
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Delphi approach
Delphi round 1
The first round resulted in low agreement on the categor-
isation of the 48 items. Several of the Delphi-members
had categorised items into several subdomains. For ex-
ample the item ‘Moral consensus for care achieved in the
patient cases’ was sorted into the following subdomains,
depending on the Delphi-member: ‘Concrete steps taken
in the patient cases’, ‘Organisation consistent with ethical
standards’ and ‘Enhanced collaboration’. This led to the
decision to discard these initial domains and create new
ones. In order to gain clarity, all subdomains were dis-
carded and the main domains were made less abstract.
The second step of item reduction resulted in 33 items
(Table 3).
Regarding the question of relevance of the items, there
was also great variability of opinions of the 48 items in
the categorisation and of the 54 items discarded by MS
and BM from literature review. There was only agree-
ment of high relevance for 10 items and agreement of
low relevance for 37 items. No differences of judgments
were detected between professions or countries.
Delphi round 2
In the second round, the appropriateness of the revised
set of 33 items and the new categorisation was tested. The
agreement between Delphi-members proved to be better
(Table 3). The most important change after the second
round was that the name of the domain ‘Improved moral
skills’ was changed into ‘Improved moral reflexivity’, in-
cluding moving one item into this domain and discarding
two others from it. The fourth and final step of item re-
duction resulted in 26 items (Table 4).
Delphi round 3
The third round resulted in 100% agreement regarding the
structure of the instrument; adequacy and clarity of the
content of instruction, questions and also the response
alternatives. After content validity testing, an additional
question in both the Euro-MCD I and II was added:
‘Please list five of the most important outcomes’. This was
done since the majority of items were viewed as “very
important”.
Content validity testing
The Content Validity Index testing
The CVI, tested mostly on the target population (Table 2)
through seven steps, showed that clarity increased from
0.71 to 0.96 and relevance from 0.70 to 0.95, although the
change in relevance was less in France ( 0.77) (Table 6).
The think-aloud interviews mainly provided input on clarity
for everyday language, highlighted ambiguities and ques-
tioning of relevance of certain items. The testing led to 35
major reformulations and 65 minor reformulations and the
discarding of two items (Table 6). No differences of judg-
ments were detected between professions or specialties.
The ‘think-aloud’ interviews and comments
The interviews and comments led to reformulations of the
items, since vague items with ambiguous meanings were
pointed out (Table 6). When the informants were uncer-
tain of the meaning of an item, they often gave suggestions
for reformulations. See summaries of the interviews in
Table 6.
Translation and CVI
The original language of the instrument is English.
Euro-MCD I and II were literally translated into Swedish,
Dutch, French and Norwegian by two independent transla-
tors for each of the languages. CVI and ‘think-aloud’ inter-
views were then tested in each country (Table 6). Next, the
versions were back-translated into English by other transla-
tors [41]. Finally, all the back-translations were compared
regarding literal translation and cultural adaption and then
harmonized against the English source [41,42]. The back-
translations showed high agreement, except for the two
Table 5 Reasons for discarding items
Reasons for discarding items Examples of discarded items
Not relevant enough for MCD Reduce feelings of bad conscience
Diminish fear of legal liability
Too unspecific; not possible to categorise
to only one domain
Strengthen confidence to see a way out
Improve ability to prioritise between clinical tasks in an ethical way
Too vague Improve quality of care in patient cases
Become aware of the tension between my personal values and actual behaviour
Too abstract Enhance moral sensitivity
Enhance knowledge of virtue ethics (such as courage, tolerance, compassion, honesty, humility)
Too academic Know how to differentiate between ethical issues and other issues (such as psychological or legal)
Enhance knowledge how to apply the four ethical principles: respect for autonomy,
non-maleficence, beneficence and justice
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Table 6 The content validity (CVI) tracking matrix
Content Validity Index CVI* (n items CVI > .78/total n items) Revision Major result of think-aloud interviews and mailed comments influencing the revision process
Steps Clarity Relevance A /B /C**
I: CVI and individual think-aloud .71 (13/26) .70 (14/26) 7/12/0 Input of reformulations into more concrete language with reductions of
double meanings for some of the items.
II: CVI and focus group interview .73 (15/26) .70 (13/26) 5/17/0 Input of reformulations of language, grammar, differentiation of group- and individual outcomes
and adding “ethics” to some items. Foremost, items belonging to the domains ‘Improvement
on organizational level’ and ‘Concrete results’ were questioned.
III: Mailed CVI .88 (23/26) .77 (14/26) 11/9/2 Input of sharper English everyday formulations from the British respondents. The Dutch respondents
foremost pointed out overlapping items, but different ones pointed out. The items “Reach answers
what the ethical problems are” and “Learn to formulate questions about ethical issues” were discarded,
due to low clarity and relevance. Two items were brought back: “Enhances my understanding of
ethical theories (ethical principles, values and norms)” and “I understand better what it means
to be a good professional”.
IV: CVI and individual think-alouds .94 (21/26) .85 (23/26) 0/2/0 In the Swedish translation, there were still ambiguous interpretations of the following items: 15, 20, 22, 23,
25 (Table 4). The critique centred on that policy work does not reach staff working on the floor and also
on the interpretation what a “good professional” is. Reformulations followed of number 22 and 23,
also in the English version.
V: CVI and focus groups .91 (24/26) .87 (20/26) 5/12/0 In the Dutch translation, the participants of the focus groups were positive about the clarity and the
relevance of the items, although some thought some were still rather abstract. Furthermore, some
thought that some items did not fit within their view on MCD. Some problems of clarity were
interpreted to be related to the translation into Dutch. Ambiguous interpretations of
item 6 and 15 (Table 4).
VI CVI and focus group .96 .77 3/6/0 In the French focus group, participants were able to see both the English and French version.
Three types of reformulation input: grammatical precision, formal clarity and substantial
clarification of terms where relevance was questioned. For example, the item 22 (Table 4)
became in French “contribute to the evolution of individual and collective practices”,
recognizing the importance of the political dimension included in the care activity.
Somewhat ambiguous interpretation of 6, 13, 15, 20 and 23.
VII CVI and individual think-alouds .95 .95 4/7/0 The Norwegians questioned foremost the clarity of the items 20 and 23, especially the meaning of
being a good professional. Revison was conducted after answers from five respondents and after next
five, the CVI was improved.
*S-CVI = the proportion of each item that achieved rating 3 or 4 divided with the number of respondents and then the average of the item-CVIs (I-CVI) [27].
**A =Major reformulation B =Minor reformulation C = Replaced.
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items in the domain Impact on organizational level. The the
terms ‘practice/policies’ were culturally translated in France
and Norway, but literally in Sweden and Netherlands.
The final instrument
The Euro-MCD consists of two sections. Section I is to be
used before MCD and consists of an open question on im-
portant outcomes in general, followed by one closed ques-
tion regarding the importance of the 26 pre-formulated
outcomes (the items). Section II is to be used after multiple
MCDs. It starts with open questions on experiences of out-
comes, followed by a series of closed questions on both the
importance and the experience of outcomes (Table 7). A
four-point response scale is used for measuring the import-
ance and the experience of outcomes: none, somewhat,
quite high and high.
The measurement model comprises 26 items and six
domains: Enhanced emotional support, Enhanced collab-
oration, Improved moral reflexivity, Improved moral atti-
tude, Impact on organizational level and Concrete results
(Table 4). Some domains are complex and thus need more
items, such as ‘Enhanced emotional support’, containing
five items. More simple and concrete domains, such as
‘Concrete results’, contain three items.
Discussion
Through a systematic process, an instrument was devel-
oped measuring a wide range of possible outcomes associ-
ated with Moral Case Deliberation in different countries:
The Euro-MCD.
The six domains in the final version - Enhanced emo-
tional support, Enhanced collaboration, Improved moral re-
flexivity, Improved moral attitude, Impact on organizational
level and Concrete results - seem to cover main outcomes
of MCD. The domains in the initial development process
contained only aspects that are directly related to ethics
(Table 4). In the final version, the domains: Enhanced emo-
tional support and Enhanced collaboration demonstrate
that reflecting (in MCD) on the morally good thing to do
also involves dealing with emotions and collaboration. Fur-
thermore, outcomes need not always be of a strictly ethical
nature in order to be considered important and relevant by
MCD users. This is also described in the literature on
MCD [43,44].
Domains similar to those in the Euro-MCD are to be
found in other validated instruments, developed outside
the area of clinical ethics support. Examples are instru-
ments concerning moral distress [45-47], nurse-physician
collaboration [48], ethical climate [46] and team reflexivity
Table 7 Open and closed questions in the two sections of the Euro-MCD instrument
Euro-MCD I (before the first MCD)
1. Imagine participating in Moral Case Deliberations. Please formulate in your own words 3 to 5 outcomes that
you consider important to reach in order to support you and your co-workers in managing ethically difficult
situations* in everyday clinical practice.
Open question
Regarding the 26 items: Closed
2. How important is each of the outcomes to you? ‘Very’
‘Quite’
‘Somewhat’
‘Not’
‘Cannot take stand’
3. Please list 5 of above outcomes that you consider as most important. Open question
Euro-MCD II (after multiple MCDs)
1. Please write down in your own words outcomes of the MCD that you have experienced during the MCD meeting(s) Open questions
2. Please write down outcomes of the MCD that you have experienced afterwards, in the everyday clinical
practice at your workplace
Regarding the 26 items: Closed
3. Have you experienced the outcome during the MCD meeting(s)? ‘In high degree’
4. Have you experienced it after the MCD, in the everyday clinical practice? ‘In quite high degree’
5. How important is the outcome to you? (Very, quite, somewhat, not, cannot take stand) ‘In some’
‘Not at all’
‘Cannot take stand’
6. Please list 5 of above outcomes that you consider as most important (irrespective whether you have experienced
them or not).
Open questions
7. What should be improved during the MCD meetings?
*ethically difficult situation was defined as “situations in which you experience unease or uncertainty of what is right or good to do or are in disagreement about
what should be done”.
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[49]. However, all these instruments measure only one
specific domain. With the Euro-MCD instrument we want
to combine several domains and relate them specifically to
MCD. Furthermore, we first want to know if there is a sys-
tematic pattern of MCD outcomes within the Euro-MCD,
and if so, which MCD outcomes are most relevant. After
testing the Euro-MCD in various countries, and further
improving its validity, existing validated instruments men-
tioned above might be used in combination with the Euro
MCD in order to evaluate to what degree the other instru-
ments and the Euro MCD measure the same construct.
A crucial aspect of the instrument is that it measures
both what the health care providers’ perceive as import-
ant and what they actually experience. It assumes that
changes in daily work after MCD sessions, reported by
respondents, are related to the participation in the MCD
sessions. Again, this is the subjective experience of the
respondents, and not in any way objectively observed.
We think, however, that this in itself is valuable and in-
formative, because the outcomes from the Euro-MCD
are experiential phenomena.
A strong point of the instrument is the multinational
and multi contextual development process [42] and thus
can be applied in a wide variety of contexts. It might
even be used in a wider sense, such as evaluating classic
ethics consultation. Furthermore, the instrument can be
used to measure changes over time through analysing
differences in perceived importance before and after
multiple MCDs.
We think the instrument can be useful, not only for
those who facilitate MCD, but also for those who imple-
ment it (e.g. managers, board of directors). The informa-
tion about the MCD outcomes could be an indicator of
the effectiveness and indirectly also of the quality of the
MCD at the local and institutional level. We think shar-
ing the results of the Euro-MCD with participants is im-
portant for testing the validity and the meaning of these
results but also, and especially, to empower MCD partic-
ipants to use the MCD for their specific interests (i.e. to
make them responsible and active owners of MCD).
Results of the Euro-MCD might also be used to develop
new ways of facilitation, since low ratings on questions on
experiencing certain outcomes during the MCD sessions
can stimulate the facilitator to change focus when facilitat-
ing future MCD’s. When for example, the rating on ‘better
mutual understanding of each other’s reasoning and act-
ing’ receives a low rating, the facilitator could focus more
on whether participants understand each other.
Methodological considerations
The development of the Euro-MCD was a complex, itera-
tive process with continuous revision of items and do-
mains. Refering to Brod’s parable of the GPS system [30],
the initial course was plotted by the literature review, but
the Delphi-panel and especially the content validity testing
corrected the wrong turns in order to make the final des-
tination. Five recommended steps out of six steps in the
development of a measurement instrument, as described
by de Vet et al. [28] was followed. The last step, field-
testing will be conducted with the current version of the
Euro-MCD. The study’s strength lies in the comprehensive
methodology in developing the Euro-MCD and the use of
standard statistical assessment at each stage. However, it
might be considered as a weakness that this instrument
does not measure objective outcomes (e.g. related to sick
leave, turnover rates of employees, and patient related out-
comes). Objective outcomes are important, but seem to be
more difficult to capture and require another kind of re-
search instrument and research design.
We selected a Delphi panel of members with high levels
of expertise [27], since the members were MCD facilita-
tors and/or ethics researchers from different countries and
with different professional backgrounds. There was also a
wide variation in respondents for the content validity
process. However, a potential bias might has been caused
by the fact that most respondents were Swedish, lacked
experience of MCD and were middle-aged. When testing
the instrument before and after multiple MCDs in the
coming field study, we will also capture younger respon-
dents with experience of MCD from four European
countries.
The process of categorization was complicated by the
diversity of opinions of the Delphi expert panel. As a
consequence, this process did not give sufficient guid-
ance for the categorization and item reduction. On the
one hand, this is an interesting result in itself: experts
on clinical ethics support vary on what kind of outcomes
they consider appropriate for MCD. On the other hand,
the low agreement between the Delphi-expert panel in
the first round could be a result from the open and im-
precise nature of the assignment given to them. In hind-
sight, we should have informed the Delphi expert panel
more clearly that the domains were seen as reflections of
the items (reflective model), not as predictions of the
items (formative model) [28]. In Delphi round 2, the
agreement of the categorization made by MS and BM
was higher and the comments were much more distinct
and helpful. It might be concluded that the first round
was too open, and the second one too narrow.
The development of the Euro-MCD is not finished. In
the coming field-study, health care providers have the op-
portunity to add items through the open questions in the
instrument. This provides the opportunity for considering
possible neglected but important outcomes in the next
version. The open questions also fit with our contextual
and pragmatic viewpoint that the specific context should
have a say in which specific goals and outcomes of MCD
are important. However, we are aware of that the number
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of items is too extensive and our goal is to decrease them
after the field-study. In this phase it could be hazardous to
limit them too much.
The content validity process was successful. This indi-
cates that we have captured and formulated clear and
relevant items, even though it was tested in only five-
Western European countries. According to Brod et al.,
combining focus-groups and individual interviews sup-
port the content validity [30]. The focus group interview
with healthcare professions working both clinically and
as researchers was especially successful. The open and
vivid communication enabled participants to equally
express their opinions. Thus, a rich variation of relevance
judgments and substantial suggestions for reformulations
were generated. The discussion of the relevance of the
item focusing on reaching consensus was especially sali-
ent. There were both strong opinions against, in that the
consensus reached may be unethical, and strong opinions
in favor, in that consensus are needed for a concrete prob-
lem in a particular patient situation.
We reached the recommended goal of a mean Content
Validity Index over .90, as recommended by Polit et al.
[27]. This means that the validity of the current items can
be considered as high. However, questions can be raised
concerning discriminative validity, since some items over-
lap. However, different respondents perceived different
items as similar. After the results of the field study, items
that overlap will be merged or deleted.
Conclusions
A tentative measurement model was developed that seems
to cover main outcomes of Moral Case Deliberation. Both
the process and the result of the content validity proce-
dures seem high. The Euro-MCD is unique since it is flex-
ible enough to be tailored to the specific needs of local
MCD groups, but general enough to capture relevant
MCD outcomes across multiple contexts.
However, a broader field study is needed to further de-
velop and validate the Euro-MCD, collecting data from
participants who have experienced multiple MCDs. Such a
study will be conducted in France, Netherlands, Norway
and Sweden. Psychometric testing will be used to evaluate
the construct validity of the measurement model. This
testing might lead to further reduction of items, but also
to addition of new ones. Further aims are to find out
whether systematic patterns of experienced outcomes and
perceived importance can be found, or whether the results
will be context sensitive.
In order to further develop and validate the instru-
ment, those who want to use the Euro-MCD, please
contact the first or last author.
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